A detailed history of Aberdeen Wealth Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Aberdeen Wealth Management LLC holds 4,475 shares of AMGN stock, worth $1.18 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
4,475
Previous 4,457 0.4%
Holding current value
$1.18 Million
Previous $1.39 Million 3.52%
% of portfolio
0.96%
Previous 0.96%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$309.38 - $337.38 $5,568 - $6,072
18 Added 0.4%
4,475 $1.44 Million
Q2 2024

Aug 02, 2024

SELL
$262.75 - $319.31 $98,531 - $119,741
-375 Reduced 7.76%
4,457 $1.39 Million
Q2 2023

Aug 03, 2023

BUY
$214.27 - $253.37 $5,356 - $6,334
25 Added 0.52%
4,832 $1.07 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $8,016 - $10,185
-35 Reduced 0.72%
4,807 $1.26 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $224 - $253
1 Added 0.02%
4,842 $1.09 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $27,047 - $30,953
136 Added 2.89%
4,841 $1.09 Million
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $8,490 - $9,948
-40 Reduced 0.84%
4,705 $1 Million
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $22,191 - $25,860
-100 Reduced 2.06%
4,745 $1.18 Million
Q4 2020

Feb 10, 2021

BUY
$216.38 - $257.67 $21,854 - $26,024
101 Added 2.13%
4,845 $1.11 Million
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $111,693 - $124,212
-476 Reduced 9.12%
4,744 $1.21 Million
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $78,134 - $95,882
395 Added 8.19%
5,220 $1.23 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $912,938 - $1.17 Million
4,825 New
4,825 $1.16 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Aberdeen Wealth Management LLC Portfolio

Follow Aberdeen Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aberdeen Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aberdeen Wealth Management LLC with notifications on news.